Dr. Shila Schneider

Consulting on mandate and temporary project basis. Evaluating business plans for and coaching of start-up companies. Swim coaching according to Total Immersion method. Open water guided swims.

Corporate licensing projects located primarily in the bone health/tissue management and gastrointestinal franchises. Lead negotiator for global OTC specialty business unit. Corporate contact for Latin American BD groups. Transacted deals for OTC products in gastroenterology for Europe, the Middle East, Latin America and South Africa. Developed branding, strategy and marketing initiatives for re-branding of Takeda business development group.

Corporate licensing projects in health/tissue management, gastrointestinal and inflammatory disease therapeutic areas. Identified, evaluated and negotiated in-market and late-stage opportunities with multi-territory and global licensing rights. Developed business development content for online, print and exhibition media for Corporate Communications. Developed and implemented business development training materials and best practice guidelines.

Out-licensing activities in Asia Pacific, South Africa, Scandinavia and Switzerland seeking new licensees for Eurand’s finished products and oral formulation technologies.

Licensing pre-clinical oncology assets and out-licensing clinical stage drug candidates with potential in solid and blood tumours.

Sourcing, evaluating and licensing technologies, therapeutic targets, drug candidates for inflammation and oncology research and development pipeline. Forging research alliances and collaborations for accessing external knowledge and developing internal capabilities.

Acquisition of new customers for bioinformatics and chemogenomics technology platform and services.

Analysis of licensing needs of the European biopharmaceutical industry for improvement of deal sourcing and business development for VC firms.

Entrepreneurship, customer-focussed strategy, pharmaceuticals and healthcare. Business plan competition winning team. Scholarship Imperial College Business School.

Molecular biology, gene therapy, rare diseases, immunology and cell biology, virology, recombinant viral vectors. PhD thesis conducted in collaboration with the Children's Hospital of the University of Zurich, Department of Immunology.

Immunology, developmental and molecular biology and biochemistry. Diploma thesis (1990-1991) with Profs. R. Zinkernagel and H. Hengartner at Institute for Experimental Immunology, University Hospital Zurich. Work experience and language studies (1989-1990).